Key Record Dates
ClinicalTrials.gov Identifier: | NCT03675737 |
---|---|
Brief Title: | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) |
First Submitted : | September 17, 2018 |
First Submitted that Met QC Criteria : | September 17, 2018 |
First Posted : | September 18, 2018 |
Last Update Submitted that Met QC Criteria : | January 22, 2021 |
Last Update Posted : | January 26, 2021 (Estimate) |